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Abstract 
 We introduce an approach for global fitting of the recently published high-throughput and 
high accuracy clonogenic cell-survival data for therapeutic scanned proton beams. Our fitting 
procedure accounts for the correlation between the cell-survival, the absorbed (physical) dose 
and the proton linear energy transfer (LET). The fitting polynomials and constraints have been 
constructed upon generalization of the microdosimetric kinetic model (gMKM) adapted to account 
for the low energy and high lineal-energy spectrum of the beam where the current radiobiological 
models may underestimate the reported relative biological effectiveness (RBE). The parameters 
ሺߙ, ߚሻ of the linear-quadratic (LQ) model calculated by the presented method reveal a smooth 
transition from low to high LETs which is an advantage of the current method over methods 
previously employed to fit the same clonogenic data. Finally, the presented approach provides 
insight into underlying microscopic mechanisms which, with future study, may help to elucidate 
radiobiological responses along the Bragg curve and resolve discrepancies between 
experimental data and current RBE models.     
  
Introduction 
 One of the main advantages of using protons and other ions in radiation therapy is the 
Bragg peak and its sharp distal dose gradient. This enables high dose delivery to deep seated 
tumors [1].   
While biological optimization is used for heavy ion therapy, for proton therapy a constant 
relative biological effectiveness (RBE) value of 1.1 continues to be employed clinically, despite 
experimental evidence that indicates a non-static RBE. A complete and robust model describing 
the cellular response and the biological effectiveness of protons along the Bragg curve would 
facilitate the biologic optimization of proton plans. However, uncertainties in the biological data at 
locations at or just distal to the Bragg-peak, where the charged particle LET is the highest, 
represent a particular challenge for the biological measurements and dose calculation in 
treatment planning systems [2-6].  
             In general, RBE depends on the radiation dose, the fractionation scheme, the biological 
endpoint, the radiation quality, dose rate, and the tissue and cell-type. Radiation quality includes 
the type of radiation, the energy and the linear energy transfer (LET) that describes the energy 
deposited from the beam into the irradiated material, per unit particle path length (in units of 
ܸ݇݁/ߤ݉). As a charged particle penetrates tissue, it slows down and its LET increases. 
Experimentally RBE reaches a maximum at a certain depth and then decreases [7]. 
A constant RBE of 1.1 has been recommended for clinical proton therapy [8, 9, 10, 11, 
12], despite the fact that variable RBE values have long been found experimentally [13, 14, 15, 
16, 17]. In vitro experimental data reveal that the RBE depends on dose and the proton energy 
spectrum at the point of measurement [13, 14]. On the other hand, in vivo biological responses 
present a more complex expression showing smaller variations in RBE values for shallow depths.  
More recent studies have shown a significant increase of RBE at the end of the proton range [15, 
16, 17, 18]. 
Given these laboratory results, it is likely necessary to develop a method to predict the 
biological effects of proton beams for given physical and geometric characteristics. One of the 
first attempts at modeling RBE based on track structure theory of heavy ions and neutrons was 
proposed by Butts and Kraft [19, 20, 21]. Implementation of such models in clinical applications 
requires physical input parameters such as, local particle energy spectrum and, biological input 
parameters, such as cell nuclear size, end damage response, etc. Currently, access to such 
parameters is lacking due to the computational complexities required to obtain them.  
Scholz, Krämer, and Kraft [22-25] implemented track structure models into particle 
radiation therapy that led to a model known as local effect model (LEM). Subsequently Paganetti 
[26] studied amorphous track structure models in proton radiation therapy and showed that the 
model needed a critical adjustment of the parameters to improve prediction. Recently, Elsasser 
et al. [27] proposed a modified local effect model which correlated spatial radiation damage and 
achieved good agreement with experimental data for different cell lines and several particle types, 
namely for protons and carbon ions.  
First principle approaches have also been tried in many studies [28, 29, 30, 36, 37]. Neary 
discussed a linear dependence of chromosome aberrations with LET [36]. Hawkins derived a 
complex exponential relationship between   and lineal-energy and LET using microdosimetric 
kinetic modeling for several cell lines [28, 29]. The Wilkens and Oelfke linear model [30] predicted 
the experimental data for LET values up to 30 ܸ݇݁/ߤ݉ [30] well but was unable to predict the 
decrease in RBE with further increases of LET. Subsequent refinements of this model were 
reported in Refs. [31] and [32]. The repair-misrepair fixation (RMF) model of chromosome 
aberration that is one of the bases of our present model and computational analysis was 
developed in Refs. [33-35]. 
The Particle Irradiation Data Ensemble (PIDE) is an effort by Gesellschaft für 
Schwerionenforschung (GSI) to organize hundreds of radiation biology experiments in one 
dataset to facilitate evaluation of RBE models [39]. Based on their analysis of over 800 cell 
survival experiments, they conclude that RBE depends on particle species and the  /β ratio and 
that using LET alone is insufficient to predict RBE. In agreement with this assessment, the 
experimental data gathered in PIDE is a good collection to examine the fitting method introduced 
in the current study. We postpone to present this study to our future works and publications. In 
addition, Mohan et al. [38] recently provided a comparison of the RBE data from Guan et al. for 
H460 non-small cell lung cancer cells to the RBE predicted by a number of models, including 
those from Wilkens and Oelfke [30], Wedenberg et al. [32], Carabe-Fernandez et al. [40], 
McNamara et al. [41], Chen and Ahmad  [42], Carlson et al. [33,51], and Frese et al. [35]. All of 
the models predicted lower RBE for the higher LET values used in the experiments. In this work 
we therefore focus on constructing a model for experimental data recently published by Guan et 
al. [37] as existing models do not adequately explain these data. 
 
             Our goal is to provide a theoretical framework in resolving the discrepancies between 
such experimental data and theoretical models. As detailed previously, the design of a graded 
solid water compensator (jig) allows irradiation of cells by a mono-energetic scanning beam of 
protons at specific depths. The absorbed dose and the proton LET were calculated using the 
Geant4 Monte Carlo toolkit [37]. Subsequent high-throughput, automated clonogenic survival 
assays were performed to spatially map the biological effectiveness of scanned proton beams 
with high accuracy. This method aims to reduce uncertainties in the biological data.  
            In this study we developed an approach for global fitting of the recently published high-
throughput and high accuracy clonogenic cell-survival data by Guan et al. 
            
 
2 Methods 
 We start by describing our phenomenological model, which is based on an extension of 
the microdosimetric kinetic model (MKM) originally proposed by Hawkins [28, 29]. We refer to our 
extension as generalized MKM (gMKM). In the following we elucidate the basis of gMKM and 
discuss in detail the differences with MKM.  
In gMKM we first incorporate the effects of particle energy deposition spatial patterns 
calculated for single-tracks with nanometer spatial resolution. The initial energy of the proton 
beam and the geometry were consistent with the experimental beam line used in Ref. [37]. The 
proton energy ranges from 80 MeV to as low as 100 keV. The choice in low energy cut-off is 
based on the range of protons with 100 keV of energy, which is less than the diameter of a cell 
nucleus, e.g., 5 ߤ݉ (typical diameter range is within 3-7 ߤ݉ depending on several factors such as 
cell type, cell cycle, adherence, etc.). To this end, we used a combination of Geant4 and Geant4-
DNA Monte Carlo toolkits (version 10.2) to simulate the track-structures in macroscopic and 
microscopic scales in water equivalent materials [43].  
We then analyzed the energy deposition distributions of protons and assessed if the 
Poisson distribution that is the central assumption in MKM effectively described the track 
structure. To this end, we randomly selected locations along the beam axis to score energy 
deposition in 5 ߤ݉-diameter spherical volumes representing cell nuclei. The dimensions of these 
volumes were consistent with the dimensions of the cell nucleus used in the clonogenic assays 
in Ref. [37].   
With these two steps, we systematically obtained the distribution of ionizations in 
geometrical structures resembling the cell nucleus as a function of their position relative to the 
source, proton energy, and LET along the radiation track.  
As shown in Figure 1a, in locations near the beam entrance where the energy of the proton 
is relatively high, i.e. 80 MeV, and therefore the LET is low, the local density of ionization within 
the cell nucleus is sparse and can be fitted by a Gaussian and/or Poisson distribution. The 
spectrum of energy loss and lineal-energies as a function of depth are plotted in Figure 2. The 
Gaussian / Poissonian approximation of energy-loss spectral density holds for a wide range of 
depths, from the entrance to locations proximal to the Bragg peak where the protons slow down 
to energies of approximately 15 MeV and LET ൎ 10	ܸ݇݁/ߤ݉. This result can be seen in Figure 1c 
where the calculated energy deposition and LET as a function of depth using Geant4 for a circular 
shape source of proton consists of a Gaussian energy broadening. 
Beyond ܮܧܶ	 ൎ 10	ܸ݇݁/ߤ݉, as shown in Figure 1b, the atomistic excitations and 
ionizations undergo a transition to a highly compact track structure. This transition in energy loss 
spectrum to a clearly visible Landau distribution [57-58] occurs around ݀ ൌ 52	݉݉ for the 80 MeV 
beam as shown in Figure 2. Therefore, above ܮܧܶ	 ൎ 10	ܸ݇݁/ߤ݉, the deviation from a Poisson 
distribution appears to be significant.  
In the Appendix we develop an analytical model based on Neyman’s distribution of type A 
(a compound Poisson distribution) [59-60] for illustration of the effects due to deviations from a 
Poisson distribution.  In the following sections, however, we present numerical results of more 
sophisticated Monte Carlo calculations. In particular in Figure 2, we present a series of lineal 
energy spectra, fitted to the Landau distribution [57,58] for a beam of protons with 80 MeV of 
energy. The spectrum evolves as an increasing function of depth (depicted in clockwise order). 
An abrupt transition in the lineal energy spectrum is seen at 5.2 cm depth where the energy 
deposition coincides with the Bragg peak (see Figure 1c) and ܮܧܶ	 ൎ 10	ܸ݇݁/ߤ݉. The transition 
in the lineal energy spectrum corresponds to a similar transition in biological responses. As 
previously demonstrated, over a wide range of depths (highlighted by a square in the energy 
deposition curve in the left) LET is low and the spectrum can be approximated by a sharp and 
symmetric Gaussian / Poissonian distribution. At high LET’s the Gaussian symmetry in lineal-
energy distribution around its statistical mean value gradually breaks down. According to this 
analysis, the non-linearity in RBE stems from this symmetry breaking in the lineal energy 
spectrum. Moreover, we attribute a decrease in RBE beyond very high LET’s, a phenomenon 
known as the over-kill effect in the literature [7], to the widening and sparsity of the lineal energy 
distribution (see for example the spectrum at ݀ ൌ 55 mm) and lack of beam strength due to a 
sharp drop in total energy deposition and particle fluence. These observations have been 
transpired to our practical approach in the fitting procedure where two kinds of linear and non-
linear polynomials were converged and fitted to the cell survival data below and beyond ܮܧܶ	 ൎ
10	ܸ݇݁/ߤ݉.  
 
We now turn to highlight the mathematical framework we employed in fitting the 
experimental data using LET power series in ߙ and ߚ. We refer the interested readers to the 
mathematical details in the Appendix.  
The results obtained from experiments [37] as well as simulations [35] confirm that as LET 
increases, ߙ and ߚ evolve from linear to non-linear functions of LET. Similar to MKM, in gMKM 
we calculated the cell survival-fraction by integrating over the solutions of the repair-misrepair-
fixation (RMF) model [33, 45, 46]. The RMF model links radiation double strand break (DSB) 
induction and the processes that lead to exchange-type chromosome aberrations and cell death. 
The linear-quadratic (LQ) survival model has been shown to be an approximate time-integrated 
solution to the RMF model that accounts for incorrect chromosome end joining. More accurate 
consideration of the RMF model by perturbative linearization of the non-linear solutions leads to 
the cell survival-fraction, ܵܨ, represented as a power series of the statistical moments of the 
specific energy ݖ in a cell-nucleus domain  
 െ lnሺܵܨሻ ൌ ܽଵݖ̅ ൅ ܽଶݖଶതതത ൅ ܽଷݖଷതതത ൅ ⋯. (1) Note that the higher order terms beyond the MKM LQ-model in Eq. (1) are from a power expansion 
of RMF solutions. Such non-linearity in SF have been examined before to analyze lack of 
symmetry in split-dose survival of mouse jejunal crypt cells where total dose was fixed but 
asymmetric combinations of the dose were used, i.e., large following small vs. small following 
large dose fractions [48]. In Eq.(1), ܽଵ, ܽଶ, … are expansion coefficients and ݖ̅, ݖଶതതത, … are the ensemble averaged moments of the specific energy. Note that ܽଵ, ܽଶ, … are combinations of the DNA-DSB induction strength constants in the RMF model and the pair-wise repair-misrepair 
chromosome end-joining rate coefficients.  
To perform the averaging in Eq.(1) explicitly, the distribution function of these random 
variables must be known. In MKM, the Poisson distribution is assumed to govern the distribution 
of ionization events. Based on our analysis, this is a plausible assumption in the low LET limit, 
however, a correction to the Poisson distribution is warranted for high LETs. We therefore expand 
the non-Poissonian distribution function of ions in the vicinity of the Poisson distribution. Following 
algebraic manipulation, an expansion around the MKM mean specific energy ݖெ̅௄ெ in Eq. (1) can be found. Using the macroscopic dose ܦ ≡ ݖ̅ and dose-averaged lineal-energy ݕௗ or equivalent ܮ (simply LET that is a linear function of ݕௗ) as two independent variables in this equation, we find     
 െ lnሺܵܨሻ ൌ ∑ ∑ ܾ௜,௝ܮ௜ି௝ܦ௝௜௝ୀଵ௡௜ୀଵ . (2) 
As described in the Appendix, derivation of Eq. (2) involves expansion of moments ݖଶതതത, ݖଷതതത, … of a 
non-Poissonian distribution, in power series of Poissonian or MKM specific energies, ݖெ̅௄ெ, ݖெ̅௄ெଶ , 
ݖெ̅௄ெଷ , …, e.g., ݖ̅ ൌ ∑ ܿ௞ݖ௞തതതெ௄ெ௞ୀଵ ; ݖଶതതത ൌ ∑ ܿ௞ݖ௞തതതெ௄ெ௞ୀଶ ; ݖଷതതത ൌ ∑ ܿ௞ݖ௞തതതெ௄ெ௞ୀଷ ; … Thus the expansion coefficients ܾ௜,௝ are linear combinations of ܽଵ, ܽଶ, … and ܿଵ, ܿଶ, ….  
Recalling ߙ and ߚ in the LQ cell-survival model, െ lnሺܵܨሻ ൌ ߙܦ ൅ ߚܦଶ, and truncating Eq. 
(2) up to the quadratic term in ܦ gives  
 ߙ ൌ ∑ ܾ௞,ଵܮ௞ିଵ௡௞ୀଵ , (3) and  
 ߚ ൌ ∑ ܾ௞ାଵ,ଶܮ௞ିଵ௡ିଵ௞ୀଵ , (4) 
with ݊ ൒ 2. In Eqs. (3) and (4) ߙ and ߚ are polynomials of LET with orders ݊ െ 1 and ݊ െ 2 
respectively, thus the formula for ܵܨ contains 2݊ െ 1 fitting parameters. For clarification of the 
compact notations used in Eqs. (3) and (4), let us consider a class of polynomials truncated at  
݊ ൌ 4, hence ߙ ൌ ܾଵ,ଵ ൅ ܾଶ,ଵܮ ൅ ܾଷ,ଵܮଶ ൅ ܾସ,ଵܮଷ and ߚ ൌ ܾଶ,ଶ ൅ ܾଷ,ଶܮ ൅ ܾସ,ଶܮଶ. A similar approach 
with slightly different representation of the RMF model as introduced by Carlson et al. [33] 
provides a more elaborate interpretation of the polynomials in the above equations. According to 
our unpublished studies, ݊ ൌ 2, 3, 4, … in ߙ and ߚ in Eqs. (3) and (4) represent the levels of 
chromosomal aberration complexities such as the binary, ternary, quaternary, etc. chromosome 
recombination. We postpone the details of the higher order (beyond binary) chromosome 
recombination leading from Neyman's distribution of type A [59,60] to our future publications.  
           In practice we aim to find an optimal ݊ that allows the best fitting of the experimental data 
with minimal number of parameters. Thus, we need to calculate a minimal ݊. The lowest possible 
݊ in Eqs. (3) and (4) corresponds to ݊ ൌ 2. This essentially corresponds to the linear ߙ and 
constant ߚ as function of LET in MKM. This model contains three fitting parameters.  
 We now turn to discuss the results of the fitting procedure for the clonogenic cell survival 
experimental data. We use global fitting of ܵܨ in a 3D parameter space using two independent 
variables ܦ and ܮ. Eq. (2) provides specific forms of polynomials that we may use to fit the data.  
 
3  Results and Discussion 
             In the current study we developed an approach for global fitting of the recently published 
high-throughput and high accuracy clonogenic cell-survival data. 
A relation between cell survival and LET was extracted in a subsequent step after the 
calculation of the linear-quadratic cell survival parameters ߙ, ߚ, ߙ/ߚ and RBE. The fitting was 
performed for each individual survival curve with a specific average LET. This method of fitting 
individually fits cell survival curves with measured data for each LET value separately, which 
would have led to high degree of variability in alpha and beta parameters of the LQ model.  
Instead, we carry out a “global” fit with the measured data.  This process reduces the overall 
uncertainty. As a result, the dependence of cell-survival data on LET exhibits fluctuations, and it 
would be challenging to fit and quantitatively interpret the results into an RBE model. The source 
of numerical noise in fitted data largely stems from uncertainties in survival data. In practice, the 
LET dependence of cell-survival data may vary among different fitting procedures. 
The data shows that the measured biologic effects are substantially greater than in most 
previous reports. It is characterized by a non-linear RBE as a function of LET near and beyond 
the Bragg peak. The calculated RBE is characterized by high sensitivity to small variations in LET 
distal to the Bragg peak, where a small uncertainty in the position of the cells may result in 
significant change in LET.  
It is therefore crucial to search for appropriate fitting procedures and algorithms to be able 
to enhance the quality of the calculated RBE and the interpretation of the data. There are several 
models in the literature predicting regular and smooth dependence of RBE parameters on LET 
including the microdosimetric kinetic model (MKM), local effect model (LEM), and Monte Carlo 
damage simulation (MCDS). In this work, we explore more reliable fitting procedures which take 
into account a correlation among the SF curves. Our method is based on a three-parameter global 
fitting. We develop an optimization procedure that allows fitting a 2D surface in a 3D parameter 
space spanned by dose, LET and cell surviving fraction (SF).    
 An extension of this approach for particles heavier than protons is currently under 
investigation and the goal for such studies is to generate data needed to optimize treatment plans 
incorporating variable RBE.   
A comparison between two schemes in global fitting using non-linear and linear 
polynomials are shown in Figures (3) and (4). In the linear polynomials fitting procedure, shown 
in Figure (4), we considered ߙ ൌ ߙ଴ ൅ ߙଵܮܧܶ; 		ߚ ൌ ߚ଴ and obtained an optimal surface in the three-dimensions spanned by dose, LET and SF that fit the experimental points whereas in the 
nonlinear approach shown in Figure (3), we used Eqs. (3) and (4). Clearly the linear fitting 
procedure can not cover the high LET data points. This is in contrast with the non-linear fitting. 
The error bar shown in these figures is extracted from the experimentally reported values in 
Ref.[37] and transformed to logarithmic scale using STD in log scale equivalent of STD/SF. Hence 
as we show the points with lower SF, the magnitude of error bars becomes more significant.  
In the non-linear fitting procedure we further divided LET into two domains of high and low 
as discussed in the Methods section. For low LET, a linear ߙ and constant ߚ which corresponds 
to choosing ݊ ൌ 2 in Eq. (2) can satisfactorily fit the data. The result of fitting for low LETs are 
shown in the left panel of Figure 5 (a and c).  
For the completeness of our discussion, we reemphasize the expected transition from 
linear to non-linear biological responses along the energy deposition curve where LET increases 
monotonically. To characterize the threshold between “low” and “high” LETs, we calculated the 
lineal energy distribution function and used it as a metric to quantify the boundary between these 
two limits. In Figure 2 we summarized the evolution of the lineal energy spectrum for a proton 
pencil beam with initial energy 80 MeV as a function of depth and LET in water. As discussed 
earlier, a transition from sharply peaked and approximately symmetric distribution in low LETs to 
highly asymmetric Landau-type distribution takes place. This transition happens in the vicinity of 
the Bragg peak where LET is approximately 10	ܸ݇݁/ߤ݉ (see also Figure 1c). We therefore 
consider this value of LET as a border in fitting the cell survival data that divides the domains of 
the low and high LETs for protons. Thus we consider ܮܧܶ	 ൎ 10	ܸ݇݁/ߤ݉ in the global fitting of cell 
survival as the value below which a linear RBE model is used whereas above ܮܧܶ	 ൎ 10	ܸ݇݁/ߤ݉ 
a non-linear RBE model is implemented.  
 It is important to mention an abrupt transition in the lineal energy distribution may be 
attributed to a similar characteristic transition in the measurable biological quantities. For example 
the measured ߙ and ߚ are the result of superposition-convolution of the corresponding 
parameters with spectrum of lineal energies, i.e., ߙሺܮሻ ൌ ׬ ߙ෤ሺݕሻܵሺݕሻ݀ݕஶ଴ , ߚሺܮሻ ൌ ׬ ߚ෨ሺݕሻܵሺݕሻ݀ݕ
ஶ
଴  
where ܮ ൌ ׬ ݕܵሺݕሻ݀ݕ/ஶ଴ ׬ ܵሺݕሻ݀ݕ
ஶ
଴ , ܵሺݕሻ is the lineal energy distribution function, and ߙ෤ and ߚ෨ are theoretically defined for a single value of lineal energy, ݕ.  
 The numerical values of the fitting parameters, presented in Table 1, were calculated 
within an in house developed Matlab code designed for an optimization algorithm in searching 
the best 2D surface fitted to a data set in 3D space. An iterative procedure was employed to 
minimize the chi-square value to obtain the optimal parameter values and performing nonlinear 
curve fitting. The optimization core of our approach uses the implementation of Levenberg-
Marquardt-Fletcher algorithm developed for nonlinear least squares fitting problems. 
 As seen in this table we obtain a satisfactory convergence with ݊ ൌ 5 and ݊ ൌ 6 for H460 
and H1437 cell lines. The rationale for selecting large values of ݊ stems from numerical methods 
in optimization and convergence of the self-consistent RBE solution in surface fitting procedure. 
The convergence of the power series can be seen from the numerical values presented in the 
table. By increasing the powers in the expansion, the numerical values of the coefficients will 
change, however, if the change in RBE resides within a convergence domain (chosen by the user) 
the optimization stops.  Although in our approach we search for optimal surfaces to minimize chi-
square values iteratively, it is known that additional metrics are needed to evaluate the goodness 
of the fit. We therefore report the calculated R-square, also known as coefficient of determination 
(COD) in Table 1. As shown in this table, the numerical values of R-square are close to 1. The 
closer the fit is to the data points, the closer R-square will be to the value of 1. It is also known 
that a larger value of R-square does not necessarily mean a better fit because of the degrees of 
freedom that can also affect the values. Thus we report the adjusted R-square values to account 
for the degrees of freedom.  
 To determine an optimal polynomial in the fitting process, we consider a series of 
polynomials corresponding to ݊ ൌ 2, 3, 4, … and perform optimization for each individual 
polynomial separately. A comparison based on chi-square and RBE is performed for 
polynomials with orders ݊ to ݊ ൅ 1. If the difference between two chi-square’s (and 
RBE’s) in steps ݊ and ݊ ൅ 1 is lower than a threshold value, e.g., |߯ଶሺ݊ ൅ 1ሻ െ	߯ଶሺ݊ሻ| ൏
ߜ, the optimization stops and chi-square and RBE corresponding to step ݊ ൅ 1 is 
reported. In low LET’s this procedure converges to a linear polynomial (as the zeros in 
Table 1 shows the contribution of higher order power series are negligible). 
 To examine the stability of the converged solutions we consider an alternative 
approach in matching the low and high LET surfaces at the boundary where ܮܧܶ ൌ 10 
keV/ߤm. To handle the discontinuity and obtain potentially smoother curves at the 
“transition point” where low LET data meet the high LET data, we include series of 
points below (and above) 10 keV/ߤm to high (and low) LET and perform the fitting 
procedure and calculate the optimum high (low) LET surfaces. We then remove these 
points located in the vicinity of the boundaries and compare the resulting surfaces with a 
simple piece-wise matching of low and high LET data at the boundaries as shown in 
Figures 7, 8 and 9. Comparison between RBE’s, alpha’s and beta’s resulted in no 
significant difference.  
In Figure 6 we show the same plots as in Figure 5 except the 3D surface is projected onto 
the SF-dose plane. The first few curves from the top in Figure 6 show the results of the ݊ ൌ 2 
fitting for LETs less than 10	ܸ݇݁/ߤ݉. In Figure 7, , ߚ, and RBE as a function of LET calculated 
from the fitted surfaces are plotted. For low LET, the linear dependence of ߙ, ߚ, and RBE is 
consistent with the fitting procedures introduced in other publications including Hawkins [28, 29], 
Wilkens and Oelfke [30] and Steinsträter et al. [44]. ߙ 
Recently McNamara et al. [41] fitted the present experimental data using a similar low-
LET methodology [25]. The result of their calculation shows that present models may 
underestimate the high LET region of the LET-RBE relationship. This issue has been resolved 
within the presented methodology of gMKM. Using the fitting approach of the constructed 
framework, the last four red curves in Figure 6 (left panel), as well as in Figure 7, exhibit a 
reasonable fit to the high LET data. In this case, polynomials of order ݊ ൌ 6 were used for ߙ and 
ߚ.   
In the right panel of Figure 6 we show the result of similar 3D global fitting using linear 
MKM polynomials, e.g., ߙ ൌ ߙ଴ ൅ ߙଵܮ and a constant ߚ. As shown in this figure, the low LET data can be fitted well by a linear ߙ and a constant ߚ, same as the left panel of Figure 6. However, for 
high LET the difference between the fitted curves and the experimental data is significant. Such 
difference can be reduced by using gMKM non-linear polynomials for ߙ and ߚ as we used for the 
fitting of high-LET data in the left panel for Figure 6.   
To illustrate the advantage of the present method, we compare the results from global 
3D fitting with the conventional fitting procedure based on the same experimental data 
published recently by Guan et al. [37].  
In the conventional fitting procedure, each survival curve with a specific LET was fitted 
individually without considering correlations among them. Hence, it may lead to irregular forms 
of ߙ and ߚ as functions of LET. This method used to fit the data in Ref. [37], is inconsistent with 
the experimental design that was intended to correlate the cell-survival data of different LETs 
along the Bragg curve. Figures 8 and 9 show comparison between the conventional and 3D 
global fitting methods.  
The presented fitting approach prevents the data from uncharacteristic 
fluctuations as shown in Figures 9 (circles). Instead it predicts a monotonic trend in ߙ/ߚ  
for all LETs [46]. Thus, the reported RBE’s in Ref. [37] corresponding to fluctuations in 
ߙ/ߚ, as shown in Figure 8, can be interpreted as an artifact associated with numerical 
instabilities in conventional fitting methods. This is consistent with a simplistic cell-
inactivation target theory as single-track lethal events becomes more common due to 
increasing LET, thus the ߙ/ߚ ratio increases. This is consistent with a simplistic cell-
inactivation target theory as single-track lethal events becomes more common due to 
increasing LET, thus the ߙ/ߚ ratio increases. 
 
   Figure 1. Two ionization-tracks of 80 MeV (a) and 1 MeV (b) protons obtained from the 
Geant4-DNA Monte Carlo simulation in water with initial points at x = y = z = 0 and directions 
parallel to z axis. The number of events in 1 MeV proton is one order of magnitude greater than 
80 MeV. Such compact ionization events in low energies clearly justify a deviation from Poisson 
distribution that may describe the ionization in 80 MeV. The relative energy deposition along 
Bragg curve and LET for a beam of proton with 80 MeV is shown in (c). The line indicates the 
position of Bragg peak at approximate 5.2 cm depth corresponding with ܮܧܶ	 ൎ 10ܸ݇݁/ߤ݉.  
 
 
 Figure 2. Series of the lineal energy spectrum and the fitting to Landau distribution is shown for 
a beam of proton with energy 80 MeV as an increasing function of depth in clockwise order. The 
x-axis and y-axis represent the lineal energy in ܸ݇݁/ߤ݉ and the histogram of lineal energy in 
ሺܸ݇݁/ߤ݉ሻିଵ. An abrupt transition in shape of the lineal energy distribution function from sharply 
symmetric to wide and asymmetric form is seen at 5.2 cm depth where ܮܧܶ	 ൎ 10	ܸ݇݁/ߤ݉ (see 
Figure 1c) and LET exceeds 10	ܸ݇݁/ߤ݉.  
 
    
   Figure 3: Experimental data of clonogenic survival fraction (SF) corresponding to H460 
(a and b) and H1437 (c and d) cells are shown in blue dots with experimental error bars in 
logarithmic scale. The surfaces are fitted to the experimental data using global 3D optimization 
using a non-linear LET model as presented in the text. The left and right figures show the views 
from low and high LETs.  
 
 
 
 
 
    
    
Figure 4: Shown same experimental data of clonogenic survival fraction (SF) for H460 (a 
and b) and H1437 (c and d) cells as in Figure 3 with a difference that a linear LET model 
corresponding to ߙ ൌ ߙ଴ ൅ ߙଵܮ and ߚ ൌ ߚ଴ have been used to obtain a globally optimal surface fitted to the experimental data. Similar to Figure 3, the left and right figures show the views from 
low and high LETs.  
 
   
    
  
Figure 5: Shown H460 (a and b) and H1437 (c and d) cell survival surfaces in low (a and c) and 
high (b and d) LETs. As discussed in the text, ܮܧܶ ൎ 10ܸ݇݁/ߤ݉ separates the low LET from high 
LET  domain for 80 MeV pencil beam of proton. The gMKM polynomials have been used in a 3D 
global fitting approach to obtain the best-fitted surface to the experimental data. The numerical 
values of the fitting parameters are in linear (a and c) and non-linear (b and d) domains are 
presented in Table 1.   
 
 
  Figure 6: 2D representation of the survival fraction shown in Figure 3 (H460 cells) using non-linear 
gMKM fitting polynomials (left panel) and linear MKM polynomials in Figure 4 (right panel). The 
black dotted lines represent the experimental data and the red lines are the fitted surfaces 
projected to the SF-Dose plane.  
 
 Figure 7: ߙ, ߚ, and RBE as a function of LET calculated analytically from ܵܨ equations 
obtained by the 3D global fitting of clonogenic cell-survival data as shown in Figures 2 and 3. 
 
 Figure 8: ߙ, ߚ, and RBE as a function of LET calculated by the conventional method and 
the presented 3D global fitting method. Although the difference in RBE between the two methods 
is negligible, the ߙ and ߚ are significantly different (H460 cells). 
 Figure 9: Lack of correlation among LETs in fitted cell-survival data in the conventional 
fitting procedure leads to strong fluctuations in ߙ/ߚ as reported by Guan et al. [37]. In contrast, 
ߙ/ߚ increases with increasing ܮܧ ௗܶ in 3D global fitting consistent with the cell inactivation target theory (H460 cells).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 H460  H460  H1437  H1437 
 Low LET High LET Low LET High LET 
ܾଵ,ଵ ‐0.21447 ‐0.12913 ‐0.05237 ‐0.12288 
ܾଶ,ଵ  ‐0.007  ‐6.733E‐03  ‐0.0151  ‐0.00624 
ܾଷ,ଵ  0  ‐4.563E‐04  0  ‐1.322E‐06 
ܾସ,ଵ  0  ‐3.37529E‐05  0  ‐9.449E‐07 
ܾହ,ଵ  0  ‐8.16229E‐06  0  ‐8.812E‐07 
ܾ଺,ଵ  0  0  0  ‐7.725E‐08 
ܾଶ,ଶ  ‐0.11061  ‐0.06864  ‐0.03265  ‐0.00382 
ܾଷ,ଶ  0  ‐0.00202  0  ‐0.0007821 
ܾସ,ଶ  0  ‐1.36897E‐04  0  ‐9.275E‐05 
ܾହ,ଶ  0  ‐3.63748E‐05  0  ‐9.511E‐07 
ܾ଺,ଶ  0  0  0  ‐1.68E‐07 
Reduced ߯ଶ  0.00487  0.07557  0.00541  0.05472 
ܴଶ (COD)  0.99496  0.98407  0.98233  0.96777 
 Adjusted ܴଶ  0.99481  0.92833  0.98233  0.93911 
Table 1. Numerical values of expansion coefficients in ߙ and ߚ given in Eqs. (3) and (4) 
for H460 and H1437 cell survivals. For a beam proton with energy 80 MeV the transition between 
low and high LETs occurs at ܮܧܶ	 ൎ 10ܸ݇݁/ߤ݉. The reduced chi-square, ߯ଶ, the	coefficients of 
determination (COD), ܴଶ, and adjusted ܴଶ have presented to illustrate the goodness of the fitting 
procedure.   
 
Conclusion 
We have developed an improved approach to fitting clonogenic survival data for 
therapeutic proton and ion beams. Our approach is based on three-parameter (3D) global fitting 
of the high-throughput, high accuracy survival fraction data acquired after irradiation with mono-
energetic proton beams. In our approach, the intrinsic correlations in cell survival data are 
incorporated into the fitting algorithm. As a result, background fluctuations of the extracted 
parameters ߙ and ߚ of the linear quadratic model due to uncertainties in the biological data are 
considerably reduced.  
To demonstrate the reduction in numerical noise, we provided a comparison between 
traditional methods of post-processing of the clonogenic survival data and our approach. The 
numerical fluctuations in RBE parameters seen when an independent fitting of cell survival data 
is performed, can be suppressed by integrating the LET models including gMKM, LEM, and 
MCDS-RMF into 3D global fitting. The latter based on gMKM predicts a gradual increase in , ߚ, 
and ߙ/ߚ as a function of LET, consistent qualitatively with the cell-inactivation target theory.  
Further studies are on the way to implement other models such as multi-scale modeling 
[52, 53] as well as MCDS-RMF into 3D global fitting of the current clonogenic survival data (that 
non-linear LET terms in ߙ and ߚ can be interpreted as higher order and more complex 
chromosome aberrations) as well as convolving the spectrum of lineal-energies, ݀ ߝ/݈݀, calculated 
by MC on ߙ and ߚ to take into account the effect of non-Poisson distribution. The latter is closely 
related to the ideas and approaches presented by Hawkins [29] and Kase et al. [54]. 
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Supplementary Materials 
 
Appendix – renormalization of radiobiological indices by energy loss fluctuations.   
This appendix describes the steps in the mathematical derivation of Eqs. (1) to (4) and the basis 
of the cell survival in the generalized microdosimetric kinetic model (gMKM) introduced in this 
study. More specifically we provide an analytical derivation of the solutions of the RMF model 
and the perturbative corrections around these solutions by taking into account the statistical 
fluctuations in energy deposition for an arbitrary distribution function, hence the renormalization 
of ߙ and ߚ. We consider a limiting case by systematically incorporating the contribution of the 
higher order fluctuations to the Gaussian distribution in energy deposition to correct the 
dependence of ߚ on lineal energy. Such perturbative expansion predicts an exact solution for ߙ 
as a linear function of lineal energy (as known in the microdosimetry literature for decades), 
while ߚ shows quadratic dependence.  
 
As pointed out in the main text, the linear density of the atomistic excitations and ionizations 
undergo a transition to a highly compact distribution as the primary protons slow down. 
Therefore, the deviation from a Poisson distribution appears to be significant at the end of the 
range of proton. Figures 1A and 1B in the main text illustrate the ionization events within the 
cellular dimensions generated by traversing a proton with initial energy of 80 MeV and 1 MeV. 
The MC simulation has performed by using Geant4 DNA. As illustrated in these figures, the 
number of events in low energies (e.g., 1 MeV) is orders of magnitude greater than high 
energies (e.g., 80 MeV). Such difference in compactness of the ionization clearly justifies 
deviation from the Poisson distribution as the proton keeps losing kinetic energy. 
 
Refs. [28,29,49] describes the original approach in mathematical formulation of the cell survival 
in the standard microdosimetric kinetic model (MKM), starting from the repair-misrepair fixation 
model (RMF) [45-46] in a cell nucleus domain. In this approach, Hawkins has shown that the 
time-integrated solution of the linearized RMF mass-action equations, averaged over the 
ensemble of the cell nucleus domains, leads to the linear-quadratic dependence of cell survival 
on the deposited dose, the first two terms in Eq.(1). Moreover this model predicts ߙ to be a 
linear function of LET and ߚ a constant and independent of LET.   
A similar approach with a distinction of including the non-linear (quadratic) term in the solutions 
of the RMF mass-action equations that accounts for the chromosome misrepair binary end-
joining leads to higher order deposited dose and LET terms. These terms in Eqs. (1) to (4) are 
effectively perturbative corrections to the linear expansion of ߙ and ߚ calculated in the MK 
model as presented in Ref. [49].  
 
Cell survival in RMF and MK model: The mass-action equations describing chromosome 
repair-misrepair binary end-joining introduced in Refs. [45-46] and [49] are given by  
 
݀݊
݀ݐ ൌ ߤݖሶ െ ߣ݊ െ ߛ݊
ଶ,										ሺܣ1ሻ 
݀ܰ
݀ݐ ൌ ߣ௅݊ ൅ ߛ௅݊
ଶ.														ሺܣ2ሻ 
 
Here ݊ and ܰ represent the number of DSBs and the lethal lesions per cell in a domain, 
equivalent of type II and I lesions in the MK model [49], respectively. ݖሶ is the microscopic dose 
rate, ߤ is the number of DSBs per domain per Gy. ߣ and ߛ are repair and binary misrepair end-
joining coefficients corresponding to DSB restitution rate and binary DSB removal rate (the 
average rate at which binary misrepair removes DSBs by using them in lethal lesions or in 
harmless rearrangement), respectively.  
  
Due to large fluctuations of energy deposition in sub-micrometer volumes, the ionizing radiation 
is characterized by the probability distribution of specific energy, and single event specific and 
lineal energies and their expectation values, the frequency-mean (ݖி, ݕிሻ, and dose-averaged (ݖ஽, ݕ஽ሻ, as well as their higher order statistical moments. The cell survival fraction is therefore given by    
 
ܵܨ ൌ ݁ିேഥ,										ሺܣ3ሻ 
 
where ഥܰ is the mean lethal lesions, averaged over specific energy distribution, in the ensemble 
of domains in all cell nuclei. 
 
Linear solutions and LQ cell survival: First we consider the linear approximation in RMF 
model, Eq. ሺܣ3ሻ, in which ߛ ൌ 0, corresponding to Eq.(7) in Ref. [49]. In this limit, the analytical 
solution of Eqs. ሺܣ1ሻ and ሺܣ2ሻ can be easily found using the Green's function method 
 
݊଴ሺݐሻ ൌ න ݀ݐᇱ
ାஶ
ିஶ
ܩ௥ሺݐ െ ݐᇱሻݖሶሺݐᇱሻ.														ሺܣ4ሻ 
 
Here ݊଴ is the solution of Eq. (A1) in the linear approximation. It is straightforward to justify that the homogeneous solution of Eq. (A1) is identical to zero, thus we do not consider it in Eq. (A4). 
It is also a straightforward calculation to show  ܩ௥ሺݐ െ ݐᇱሻ ൌ ߤ݁ିఒ൫௧ି௧ᇲ൯ߠሺݐ െ ݐᇱሻ, where ߠሺݐ െ ݐᇱሻ is the Heavyside function, i.e., ߠ ൌ 1 if ݐ ൒ ݐᇱ and 0 otherwise. The steps in calculating retarded 
Green’s function, ܩ௥, include converting the integral equation, Eq. (A4), to a differential equation for ܩ by substituting (A4) in (A1) and imposing the initial condition ത݊଴ ൌ 0 for ݐ ൏ 0 where ݖሶ ൌ 0. 
Similarly we define	ܵܨ଴ ൌ ݁ିேഥబ where ഥܰ଴ ൌ ׬ ݀ݐᇱାஶିஶ ൣߣ௅ ത݊଴ ൅ ߛ௅݊଴ଶതതത൧. Here the bar over ଴ܰ denotes energy deposition averaging on the ensemble of cell nuclei domains, specific to a lineal-energy 
distribution.  
For an acute radiation dose, ݖሶሺݐሻ ൌ ݖߜሺݐሻ, the solution of Eq.(A4), ݊଴ሺݐሻ ൌ ߤݖ݁ିఒ௧ߠሺݐሻ, leads to 
ഥܰ଴ ൌ ఒಽఒ ߤݖ̅ ൅
ఊಽ
ଶఒ ߤଶݖଶതതത. By averaging over the lineal-energy distribution and all cell nuclei and their domains we obtain a linear-quadratic model in cell-survival 
 
െ lnሺܵܨሻ ൌ ߙݖ̅ ൅ ߚݖ̅ଶ,											ሺܣ5ሻ 
 
where ߙ ൌ ఒಽఒ ߤ ൅
ఊಽ
ଶఒ ߤଶݖ஽ and ߚ ൌ
ఊಽ
ଶఒ ߤଶ. Here we use the identity ݖଶതതത ൌ ݖ̅ሺݖ̅ ൅ ݖ஽ሻ [50] that accounts for the spatial averaging of the energy deposition fluctuations, where	ݖ஽ ൌଵ
௭ಷ ׬ ݖ
ଶ ଵ݂ሺݖሻ݀ݖஶ଴ , ݖி ൌ ׬ ݖ ଵ݂ሺݖሻ
ஶ
଴ ݀ݖ and ଵ݂ሺݖሻ is the single event distribution function of specific 
energy deposition, a counterpart distribution function of the lineal-energy ݂ሺݕሻ. Furthermore ݖ̅ ൌ
׬ ݖܨሺݖ; ்݊ሻ݀ݖஶ଴ ൌ ்݊ݖி where ܨሺݖ; ்݊ሻ is distribution function accounting for all events and ்݊ is mean number of events and/or tracks. Applying a relation between ݖ and ݕ (see e.g., Eq.(II.28) 
in Ref. [49] or Eq. (8) in Ref. [54]), ݖ஽ ൌ ݈ሺݕ஽/݉ሻ, where ݉ ൌ ߩܸ	and ݈ are the average mass and the chord length of a MKM domain, with ߩ and ܸ, the mass density and the average volume 
of the domains, we obtain ߙ ൌ ఒಽఒ ߤ ൅
ఊಽ
ଶఒ ߤଶ
ଵ
ఘሺ௏/௟ሻ ݕ஽. Considering the RMF and MKM constants in 
ߙ and ߚ as phenomenological parameters we end up with two relations frequently used in the 
literature for fitting RBE data, (see for example Refs. [49,54])  
 
ߙ ൌ ߙ଴ ൅ ߚ 1ߩߨݎௗଶ ݕ஽; 		ߚ ൌ ߚ௫.																		ሺܣ6ሻ  
Here ߙ଴, ߚ௫, and ݎௗ (the radius of a spherical domain) are the phenomenological fitting parameters.  
 
Non-linear expansion of RMF solutions, going beyond LQ cell survival: We now turn to 
perform a perturbative expansion to calculate the non-linear solution of the RMF model, Eqs. 
(A1) and (A2). To go beyond the RMF linear solutions presented above, we assume ߛ to be a 
small parameter, hence we expand ݊ about ݊଴ perturbatively and linearize the resulting mass-action kinetic equation to obtain the dynamics of the small fluctuations describing deviations 
from linear DSB solutions. We define ݊ଵ ൌ ݊ െ ݊଴ and recall Eq. (A1) to obtain a linear mass-action equation for ݊ଵ   
݀݊ଵ
݀ݐ ൌ െߣ݊ଵ െ ߛሺ2݊଴݊ଵ ൅ ݊଴
ଶሻ ൅ ܱሺ݊ଵଶሻ.									ሺܣ5ሻ 
 
Here ݊ is the exact solution of the RMF model. As we defined, ݊଴ is the linear solution of the RMF model, hence ݊ଵ describes the difference between exact and linear solutions. It is more convenient to transform Eq. (A5) into a more compact form 
 
݀݊ଵ
݀ݐ ൅ ߟሺݐሻ݊ଵሺݐሻ ൌ ߦሺݐሻ,							ሺܣ6ሻ  
where ߟ ൌ ߣ ൅ 2ߛ݊଴ and ߦ ൌ ߛ݊଴ଶ. The solution of Eq. (A6) can be calculated exactly    
݊ଵሺݐሻ ൌ ݁ିఝሺ௧ሻ න ݀ݐᇱߦሺݐᇱሻ݁ఝ൫௧ᇲ൯,
௧
ିஶ
									ሺܣ7ሻ 
 
where ߮ሺݐሻ ൌ ߣݐ ൅ 2ߛ ׬ ݀ݐ′݊଴ሺݐᇱሻ௧ିஶ . Linearizing Eq. (A7) in terms of ߛ, assuming ߛ is a small parameter, leads to  
 
݊ଵሺݐሻ ൌ ߛ݁ିఒ௧ න ݀ݐ′݊଴ଶሺݐᇱሻ݁ఒ௧ᇲ
௧
ିஶ
൅ ܱ ቆߛ
ଶ
ߣଶቇ.						ሺܣ8ሻ 
 
Substituting the linear solution calculated above, ݊଴ሺݐሻ ൌ ߤݖ݁ିఒ௧ߠሺݐሻ, in Eq. (A8) yields   
݊ଵሺݐሻ ൌ ߛߣ ߤ
ଶݖଶ൫1 െ ݁ିఒ௧൯݁ିఒ௧,														ሺܣ9ሻ 
 
hence  
 
݊ ൌ ݊଴ ൅ ݊ଵ ൌ ݊଴ െ ߛߣ ሾ݊଴ െ ߤݖሿ݊଴ ൅ ܱሺ݊଴
ଷሻ.											ሺܣ10ሻ 
 
From Eq.(A10) and ݊଴ the cell-survival can be calculated, െ lnሺSFሻ ൌ׬ ݀ݐᇱାஶିஶ ൣߣ௅ ത݊ ൅ ߛ௅݊ଶതതത൧, hence 
 
െ lnሺSFሻ ൌߣ௅ߣ ߤݖ̅ ൅
1
2 ൤
ߣ௅
ߣ
ߛ
ߣ ൅
ߛ௅
ߣ ൨ ߤ
ଶݖଶതതത ൅ 13
ߛ௅
ߣ
ߛ
ߣ ߤ
ଷݖଷതതത ൅ ቈെ ߛ௅6ߣ
ߛଶ
ߣଶ ߤ
ସݖସതതത ൅ ܱ ቆߛ
ଶ
ߣଶ ݖସതതതቇ቉
൅ ܱ൫ݖହതതത൯											ሺܣ11ሻ 
 
The last two terms in Eq. (A11) are the contribution of the terms omitted in Eq. (A8) due to 
linearizing ݊ in the limit where ߛ is negligible. To transform (A11) to a form similar to the linear-
quadratic model we must calculate the statistical fluctuations in microscopic dose deposition 
throughout the averaging over cell nucleus domains, assuming equivalence between the 
ensemble averaging over the domains and the spatial averaging of the energy deposition 
fluctuations over the cell nuclei. In general, these fluctuations can be recursively reduced to 
lower power fluctuations, namely 
ݖଶതതത ൌ ݖ̅ଶ ൅ ݖଶଵݖ̅,								ሺܣ12ܽሻ 
ݖଷതതത ൌ ݖ̅ଷ ൅ ݖଷଶݖ̅ଶ ൅ ݖଷଵଶ 	ݖ̅	,								ሺܣ12ܾሻ 
ݖସതതത ൌ ݖ̅ସ ൅ ݖସଷݖ̅ଷ ൅ ݖସଶଶ ݖ̅ଶ ൅	ݖସଵଷ ݖ̅	.							ሺܣ12ܿሻ  
… 
and in general  
ݖపഥ ൌ ෍ݖ௜௝௜ି௝
௜
௝ୀଵ
ݖ̅௝ 
Here ݖ௜௝ are coefficients in the expansion with the physical dimension identical to the dimension 
of specific energy, Gy, and can be calculated by integrating over single event energy deposition 
distribution, ଵ݂ሺݖሻ. For example ݖଶଵ ൌ ݖ஽, ݖଷଵଶ ൌ ଵ௭ಷ ׬ ݖ
ଷ ଵ݂ሺݖሻ݀ݖஶ଴ , ݖଷଶ ൌ 3ݖ஽, ݖସଵଷ ൌ
ଵ
௭ಷ ׬ ݖ
ସ ଵ݂ሺݖሻ݀ݖஶ଴ , 
ݖସଶଶ ൌ 3ݖ஽ଶ ൅ 4ݖଷଵଶ , ݖସଷ ൌ 6ݖ஽, …  
Applying Eqs. (A12a) to (A12c) in Eq. (A11) and keeping up to the quadratic term in 
macroscopic dose, ܦ ൌ ݖ̅, we find 
 
െ lnሺSFሻ ൌ ൤ߣ௅ߣ ߤ ൅
1
2 ൬
ߣ௅
ߣ
ߛ
ߣ ൅
ߛ௅
ߣ ൰ ߤ
ଶݖଶଵ ൅ 13
ߛ௅
ߣ
ߛ
ߣ ߤ
ଷݖଷଵଶ ൅ ⋯ ൨ ݖ̅
൅ ൤12 ൬
ߣ௅
ߣ
ߛ
ߣ ൅
ߛ௅
ߣ ൰ ߤ
ଶ ൅ 13
ߛ௅
ߣ
ߛ
ߣ ߤ
ଷݖଷଶ ൅ ⋯ ൨ ݖ̅ଶ ൅ ⋯										ሺܣ13ሻ 
 
Hence  
 
ߙ ൌ ߣ௅ߣ ߤ ൅
1
2 ൬
ߣ௅
ߣ
ߛ
ߣ ൅
ߛ௅
ߣ ൰ ߤ
ଶݖଶଵ ൅ 13
ߛ௅
ߣ
ߛ
ߣ ߤ
ଷݖଷଵଶ ൅ ⋯														ሺܣ14ሻ 
 
ߚ ൌ 12 ൬
ߣ௅
ߣ
ߛ
ߣ ൅
ߛ௅
ߣ ൰ ߤ
ଶ ൅ 13
ߛ௅
ߣ
ߛ
ߣ ߤ
ଷݖଷଶ ൅ ⋯													ሺܣ15ሻ 
 
In the limit where ߛ ൌ 0, Eqs. (A14) and (A15) reduce to ߙ ൌ ఒಽఒ ߤ ൅
ఊಽ
ଶఒ ߤଶݖ஽ and ߚ ൌ
ఊಽ
ଶఒ ߤଶ, the linear MKM approximation [46]. By expanding ݖ௜௝ around ݖ஽ in Eqs. (A14) and (A15), e.g., 
׬ ݖ௡ ଵ݂ሺݖሻ݀ݖ ൌ ׬ ሺݖ஽ ൅ ߜݖሻ௡ ଵ݂ሺݖሻ݀ݖஶ଴ ൌ ∑
௡!
௞!ሺ௡ି௞ሻ! ݖ஽௞௡௞ୀ଴ ׬ ሺݖ െ ݖ஽ሻ௡ି௞ ଵ݂ሺݖሻ݀ݖ
ஶ
଴ ൌ
ஶ
଴
∑ ௡!௞!ሺ௡ି௞ሻ! ݖ஽௞௡௞ୀ଴ ሚ݂௡ି௞ሺݖ஽ሻ where ߜݖ ൌ ݖ െ ݖ஽ and ሚ݂௞ሺݖ஽ሻ ൌ ׬ ሺݖ െ ݖ஽ሻ௞ ଵ݂ሺݖሻ݀ݖ
ஶ
଴ , and using ݖ௜௝ ൌ
݈ݕ௜௝/݉, and a linear relationship between ݕ஽	and ܮ [55,56], one may find ߙ and ߚ to be a power 
series in lineal energy and LET as given by Eq.(3) and (4). The constants in Eqs. (A14) and 
(A15) can be determined phenomenologically by fitting ߙ and ߚ to the experimental data as 
illustrated in the text, i.e., ߙ ൌ ∑ ܾ௞,ଵܮ௞ିଵ௡௞ୀଵ , and ߚ ൌ ∑ ܾ௞ାଵ,ଶܮ௞ିଵ௡ିଵ௞ୀଵ . As seen in these equations, the contribution from the energy loss fluctuations renormalizes the LQ biological 
parameters ߙ and ߚ to infinite orders in ݖ஽ and ݕ஽.   
Gaussian fluctuations 
It is interesting to calculate ݖ௜௝, ߙ and ߚ for a widely used Gaussian distributed function as in the 
limit ݖ̅ ≫ 0, the Poisson distribution can be approximated to a Gaussian (central limit theorem) 
with variance ߪଶ ൌ ݖீ஽ݖ̅ீ  
ܨሺݖ; ்݊ሻ ⟶ ீܨ ሺݖ; ்݊ሻ ൌ 1ߪ√2ߨ exp ቆെ
ሺݖ െ ݖ̅ீ ሻଶ
2ߪଶ ቇ 
Here we change the notations ⟶ ீܨ , ݖ̅ ⟶ ݖ̅ீ , ݖி ⟶ ݖீி	and ݖ஽ ⟶ ݖீ஽ with the subscript ܩ to denote the averaging over the Gaussian distribution function. It is straightforward calculation to 
find the Gaussian version of equations (A12a – A12c) 
ݖଶതതത ⟶ ݖଶீതതത ൌ ݖ̅ீଶ ൅ ݖீ஽ݖ̅ீ 	,							ሺܣ12݀ሻ 
ݖଷതതത ⟶ ݖଷீതതത ൌ ݖ̅ீଷ ൅ 3ݖீ஽ݖ̅ீଶ,								ሺܣ12݁ሻ 
ݖସതതത ⟶ ݖସீതതത ൌ ݖ̅ீସ ൅ 6ݖீ஽ݖ̅ீଷ ൅ 3ݖீ஽ଶ ݖ̅ீଶ,							ሺܣ12݂ሻ 
ݖହതതത ⟶ ݖହீതതത ൌ ݖ̅ீହ ൅ 10ݖீ஽ݖ̅ீସ ൅ 15ݖீ஽ଶ ݖ̅ீଷ,							ሺܣ12݃ሻ 
ݖ଺തതത ⟶ ݖ଺ீതതത ൌ ݖ̅ீ଺ ൅ 15ݖீ஽ݖ̅ீହ ൅ 45ݖீ஽ଶ ݖ̅ீସ ൅ 15ݖீ஽ଷ ݖ̅ீଷ,							ሺܣ12݄ሻ 
						… 
where all statistical fluctuations and higher order moments are reduced to two variables ݖீ஽ ൌଵ
௭ಸಷ ׬ ݖ
ଶ݂ீ ଵሺݖሻ݀ݖஶ଴  and ݖ̅ீ ൌ ்݊ݖீி where ݖீி ൌ ׬ ݖ݂ீ ଵሺݖሻ
ஶ
଴ ݀ݖ. A comparison between Eqs. (A12d 
– A12f) and (A12a – A12c) shows that ݖீ,ଶଵ ൌ ݖ஽, ݖீ,ଷଶ ൌ 3ݖ஽, ݖீ,ଷଵ ൌ 0, ݖீ,ସଷ ൌ 6ݖ஽, ݖீ,ସଶ ൌ
√3ݖ஽, ݖீ,ସଵ ൌ 0,… Note that the fluctuations such as 	ݖீ,ଷଵ, ݖீ,ଷଶ, ݖீ,ସଵ are negligible because of 
specific symmetry of ܩሺݖሻ. 
 
Similar to a general energy loss fluctuations, the contributions of the Gaussian fluctuations in 
energy deposition introduce correction factors to ߙ and ߚ. Because the contribution to ݖ̅ீ  from 
ݖଷீതതത and beyond are identical to zero, there is no correction beyond the linear term in ݖீ஽ and 
hence in ݕீ஽. This is evident from Eq. ሺܣ12݁ሻ as the lowest order correction to specific energy and deposition dose is quadratic. Hence the Gaussian model predicts ߙ to be only linear 
dependence on lineal energy and LET  
ߙீ ൌ ߣ௅ߣ ߤ ൅
1
2 ൬
ߣ௅
ߣ
ߛ
ߣ ൅
ߛ௅
ߣ ൰ ߤ
ଶݖீ஽.														ሺܣ16ሻ 
Similarly for ߚ the corrections beyond ݖହതതത fluctuations vanish exactly as the lowest order 
correction to the dose in Eq. ሺܣ12݃ሻ is cubic. Hence we find a closed form for ߚ 
ߚீ ൌ 12 ൬
ߣ௅
ߣ
ߛ
ߣ ൅
ߛ௅
ߣ ൰ ߤ
ଶ ൅ ߛ௅ߣ
ߛ
ߣ ߤ
ଷݖீ஽ ൅ ൭െ ߛ௅6ߣ
ߛଶ
ߣଶ ൅ ܱ ቆ
ߛଶ
ߤସߣଶቇ൱ 3ߤ
ସݖீ஽ଶ .													ሺܣ17ሻ 
As seen in these equations, the contribution from the fluctuations in Gaussian model of energy 
deposition correct the LQ biological parameters ߙீ and ߚீ to scale linearly and quadratically in ݖ஽ and ݕ஽. We note that the radio-biological models that start from the equations equivalent of ሺܣ16ሻ and ሺܣ17ሻ are implicitly assuming a Gaussian-type symmetry in the energy-loss 
processes. This includes models with linear dependence on LET in ߙ and constant ߚ (e.g., by 
neglecting higher order ߤ terms in ߙ and ߚ beyond quadratic terms). Such models neglect the 
importance of asymmetries hidden in more realistic distribution functions such as the Landau 
[57] and/or Vavilov [58] distribution functions, responsible for observed non-linearities in 
biological responses.  
 
 
Neyman's distribution of type A and DSB distribution 
 
We devote this section to illustrate the effect of deviation from Poisson distribution on statistical 
fluctuations of specific energy, DSB distribution, and biological indices ߙ and ߚ. Specifically we 
start with construction of the Neyman’s distribution function from first principles for DSB 
induction processes and calculate the higher order moments in specific energy needed for 
incorporation of the repair and mis-repair mechanisms to fit globally the cell survival data.  
 
We consider the normalized distribution function to describe stochastic energy deposition in 
DNA material [50,55] as given below 
ܨሺݖ; ̅ߥሻ ൌ ෍݌ఔሺ̅ߥሻ
ஶ
ఔୀ଴
ఔ݂ሺݖሻ,																			ሺܣ18ሻ 
where ݌ఔሺ̅ߥሻ ൌ ሺ̅ߥఔ/ߥ!ሻexp	ሺെ̅ߥሻ describes the Poisson distributed events in an ensemble of single tracks. Here ̅ߥ denotes the average number of energy deposition events and ఔ݂ሺݖሻ is the distribution of specific energy imparted from passage of a single track within ݖ and ݖ ൅ ݀ݖ 
resulted from exactly ߥ energy deposition events. The stochastic process as such is sketched in 
Fig. (1A). 
 
We denote ߝఔ the deposited energy resulted from exactly ߥ events in mass ݉ of DNA material 
corresponding to specific energy ݖ ൌ ଵ௠∑ ߝ௜ఔ௜ୀଵ ൌ ߥߝఔഥ /݉ where ߝఔഥ ൌ
ଵ
ఔ ∑ ߝ௜ఔ௜ୀଵ . The occurrence of ݇ DSBs resulted from energy deposition requires balance in energy transfer to DNA. More 
specifically ߥߝఔഥ ൌ ߥ ∑ ߳௜ ൌ ݇߳୼̅୼௜ୀଵ  where ߳୼̅ ൌ ଵ୼∑ ߳௜୼௜ୀଵ  is the typical energy results in breaking chemical bonds for induction of a single DSB and ݇ ൌ ߥΔ ൌ 0,1,2, … counts number of DSBs. Δ is 
the number of induced DSBs in an event. Hence the energy balance in an exactly ߥ events 
processes requires ݖ ൌ ߳୼̅ߥΔ/݉. Further simplification can be performed by averaging over DSB 
population per event subsequently by averaging over events that yields ധ݇ ൌ ߥΔതതതത ൌ ̅ߥΔഥ. Here Δഥ is 
average number of DSBs per event, independent of ߥ. The double bars over ݇ denotes two 
independent averagings; hence the order of averaging is not an issue. Also note that ݊ ൌ ധ݇ and 
ߤ ൌ ݉/߳୼̅ in Eq.(A1) hence ݖሶ ൌ ሺΔഥ/ߤሻ̅ߥሶ.   
The distribution of DSBs in a class of events, specified by given ߥ, can be uniquely determined 
by the corresponding energy deposition distribution. The DSB partition function, ܳ௞ሺΔഥ; ̅ߥሻ, the probability distribution in finding exactly ݇ DSBs, can be calculated from Eq.(A18) where ఔ݂ሺݖሻ ൌ∑ ݌௞ሺݖሻߜሺݖ െ ߥΔഥ/ߤሻஶ௞ୀ଴ . The insertion of ߜ-function, the DSB density of states, enforces a constraint on the energy transfer balance resembling Fermi golden rule formulation of transition 
rates and the perturbation theory in quantum physics. Substituting ఔ݂ሺݖሻ in Eq.(A18) and integrating over ݖ yields  
1 ൌ න ܨሺݖ; ̅ߥሻ
ஶ
଴
݀ݖ ൌ ෍݌ఔሺ̅ߥሻ
ஶ
ఔୀ଴
න ෍݌௞ሺݖሻߜሺݖ െ ߥΔഥ/ߤሻ
ஶ
௞ୀ଴
ஶ
଴
݀ݖ
ൌ ෍෍݌ఔሺ̅ߥሻ݌௞ሺߥΔഥሻ ൌ ෍ܳ௞ሺΔഥ; ̅ߥሻ
ஶ
௞ୀ଴
ஶ
ఔୀ଴
ஶ
௞ୀ଴
,																	ሺܣ19ሻ 
Thus  
ܳ௞ሺΔഥ; ̅ߥሻ ൌ ෍݌ఔሺ̅ߥሻ݌௞ሺߥΔഥሻ
ஶ
ఔୀ଴
.																	ሺܣ20ሻ 
Further approximation can be performed by considering Poisson distribution for DSB events, 
i.e., ݌௞ሺߥΔഥሻ ൌ ሺߥΔഥሻ௞/݇! exp	ሺെߥΔഥሻ that reduces ܳ௞ሺΔഥ; ̅ߥሻ in Eq.(A20) to Neyman’s distribution of Type A (see for example Refs. [57,58]). Accordingly, the probability in finding a DNA with zero 
DSB is given by ܳ଴ ൌ exp	ሺെ̅ߥሺ1 െ exp	ሺെΔഥሻሻሻ ൎ exp	ሺെ̅ߥΔഥሻ. In this equation, ̅ߥΔഥ is the average number of events times the average number of DSBs per event.  
 
From Eq. (A20), it is now straightforward to calculate the statistical moments of DSBs and the 
corrections to biological indices ߙ and ߚ by inclusion of DSB fluctuations, as discussed in the 
main text. Here we systematically show that the DSB partition function given by ܳ௞ሺΔഥ; ̅ߥሻ in Eq. (A20) provides all statistical moments we need for this analysis. For clarification of notations we 
first check the self-consistency of equations by calculating the first moment 
ധ݇ ൌ ෍݇ܳ௞ሺΔഥ; ̅ߥሻ ൌ ̅ߥΔഥ
ஶ
௞ୀ଴
. 
Furthermore  
݇ሺ݇ െ 1ሻധധധധധധധധധധധ ൌ ෍݇ሺ݇ െ 1ሻܳ௞ሺΔഥ; ̅ߥሻ ൌ ሺ̅ߥΔഥሻଶ ൅ ሺ̅ߥΔഥሻΔഥ
ஶ
௞ୀ଴
ൌ ധ݇ଶ ൅ ധ݇Δഥ, 
݇ሺ݇ െ 1ሻሺ݇ െ 2ሻധധധധധധധധധധധധധധധധധധധധധ ൌ ෍݇ሺ݇ െ 1ሻሺ݇ െ 2ሻܳ௞ሺΔഥ; ̅ߥሻ
ஶ
௞ୀ଴
ൌ ധ݇ଷ ൅ 3ധ݇ଶΔഥ ൅ ധ݇Δഥଶ, 
and in general  
 
݇ሺ݇ െ 1ሻሺ݇ െ 2ሻ… ሺ݇ െ ݎሻധധധധധധധധധധധധധധധധധധധധധധധധധധധധധധധധധ ൌ ෍ܿ௦ ധ݇௥ି௦ାଵΔഥ௦
௥
௦ୀ଴
.																		ሺܣ21ሻ 
Here ܿ௦ are the coefficients of expansion and ܿ଴ ൌ 1. By further expansion of Eq. (A21) we find a power law series dependence of DSB fluctuations on Δ that we need for the expansion of Eqs. 
(A1) and (A2)  
݇௥ധധധ ൌ ധ݇௥ ൅ ሺܽ଴ଵ ൅ ܽଵଵΔഥሻധ݇௥ିଵ ൅ ሺܽ଴ଶ ൅ ܽଵଶΔഥ ൅ ܽଶଶΔഥଶሻധ݇௥ିଶ ൅ ⋯
൅ ሺܽ଴௥ ൅ ܽଵ௥Δഥ ൅ ܽଶ௥Δഥଶ ൅⋯൅ ܽ௥௥Δഥ௥ሻധ݇.																		ሺܣ22ሻ  
 Figure 1A. Schematically shown the energy deposition of ߥ ൌ3 events resulted from passage of 
a single track in a cell domain.  
 
Finally we show that Δഥ ൌ ߤݖ஽. This identity is the reminiscent of fluctuation-dissipation theorem and can be derived in the following steps 
ݖଶതതത
ݖ̅ ൌ
׬ ݖଶஶ଴ ܨሺݖ; ̅ߥሻ݀ݖ
׬ ݖஶ଴ ܨሺݖ; ̅ߥሻ݀ݖ
ൌ
∑ ݌ఔሺ̅ߥሻஶఔୀ଴ ׬ ݖଶ݀ݖஶ଴ ∑ ݌௞ሺݖሻߜ ൬ݖ െ
ߥΔഥ
ߤ ൰ஶ௞ୀ଴
∑ ݌ఔሺ̅ߥሻஶఔୀ଴ ׬ ݖஶ଴ ݀ݖ ∑ ݌௞ሺݖሻߜ ൬ݖ െ
ߥΔഥ
ߤ ൰ஶ௞ୀ଴
. 
After integrating over ߜ-function we find 
 
ݖଶതതത
ݖ̅ ൌ
∑ ∑ ݌ఔሺ̅ߥሻ݌௞ሺߥΔഥሻሺߥΔഥ/ߤሻଶஶఔୀ଴ஶ௞ୀ଴
∑ ∑ ݌ఔሺ̅ߥሻ݌௞ሺߥΔഥሻஶఔୀ଴ஶ௞ୀ଴ ሺߥΔഥ/ߤሻ ൌ
Δഥ
ߤ
∑ ߥଶ݌ఔሺ̅ߥሻ ∑ ݌௞ሺߥΔഥሻஶ௞ୀ଴ஶఔୀ଴
∑ ߥ݌ఔሺ̅ߥሻ ∑ ݌௞ሺߥΔഥሻஶ௞ୀ଴ஶఔୀ଴ .  
Because ∑ ݌௞ሺߥΔഥሻஶ௞ୀ଴ ൌ 1 and ∑ ߥଶ݌ఔሺ̅ߥሻஶఔୀ଴ ൌ ߥଶതതത ൌ ̅ߥሺ̅ߥ ൅ 1ሻ and ∑ ߥ݌ఔሺ̅ߥሻஶఔୀ଴ ൌ ̅ߥ we find 
ݖଶതതത
ݖ̅ ൌ
Δഥ
ߤ ሺ̅ߥ ൅ 1ሻ,	 
hence Δഥ ൌ ሾߤ/ሺ̅ߥ ൅ 1ሻሿ൫ݖଶതതത/ݖ̅൯. For a class of single events, ݖଶതതത/ݖ̅  reduces to ݖ஽. More specifically  
ݖ஽ ൌ ݖ
ଶതതത
ݖ̅ ቤఔୀଵ
ൌ ׬ ݖ
ଶஶ
଴ ܨሺݖ; ̅ߥሻ݀ݖ
׬ ݖஶ଴ ܨሺݖ; ̅ߥሻ݀ݖ
อ
ఔୀଵ
ൌ
∑ ݌ఔሺ̅ߥሻஶఔୀ଴ ׬ ݖଶ݀ݖஶ଴ ∑ ݌௞ሺݖሻߜ ൬ݖ െ
ߥΔഥ
ߤ ൰ ߜఔ,ଵஶ௞ୀ଴
∑ ݌ఔሺ̅ߥሻஶఔୀ଴ ׬ ݖஶ଴ ݀ݖ ∑ ݌௞ሺݖሻߜ ൬ݖ െ
ߥΔഥ
ߤ ൰ ߜఔ,ଵஶ௞ୀ଴
. 
Similarly after integrating over ߜ-function we find 
 
ݖ஽ ൌ
∑ ∑ ݌ఔሺ̅ߥሻ݌௞ሺߥΔഥሻሺߥΔഥ/ߤሻଶߜఔ,ଵஶఔୀ଴ஶ௞ୀ଴
∑ ∑ ݌ఔሺ̅ߥሻ݌௞ሺߥΔഥሻஶఔୀ଴ஶ௞ୀ଴ ሺߥΔഥ/ߤሻߜఔ,ଵ ൌ
Δഥ
ߤ
∑ ߥଶ݌ఔሺ̅ߥሻ ∑ ݌௞ሺߥΔഥሻߜఔ,ଵஶ௞ୀ଴ஶఔୀ଴
∑ ߥ݌ఔሺ̅ߥሻ ∑ ݌௞ሺߥΔഥሻஶ௞ୀ଴ஶఔୀ଴ ߜఔ,ଵ ൌ
Δഥ
ߤ. 
 
Combining the results of these equations into Eq.(A22) and using transformation, ݇ ⟶ ߤݖ in 
Eq.(A22) and multiplying that equation by ߤି௥ and substituting Δഥ ൌ ߤݖ஽, we obtain 
ݖ௥തതത ൌ ݖ̅௥ ൅ ሺܾ଴ଵ ൅ ܾଵଵݖ஽ሻݖ̅௥ିଵ ൅ ሺܾ଴ଶ ൅ ܾଵଶݖ஽ ൅ ܾଶଶݖ஽ଶሻݖ̅௥ିଶ ൅ ⋯൅ ሺܾ଴௥ ൅ ܾଵ௥ݖ஽ ൅ ܾଶ௥ݖ஽ଶ ൅ ⋯൅ ܾ௥௥ݖ஽௥ ሻݖ̅.																		ሺܣ32ሻ Here ܾ௦௥ ൌ ܽ௦௥ߤ௦ି௥ are the expansion coefficients. In numerical fitting procedure to the experimental cell-survival data we consider these coefficients as phenomenological adjustable 
parameters. Recalling ݖ஽ ൌ ݈ሺݕ஽/݉ሻ and following the derivation steps presented in previous section, we arrive at similar expressions for ߙ and ߚ and the power series dependences on 
lineal energy. 
 
The results given in Eqs. (A19-A22) for Neyman’s distribution is in contrast with the Poisson 
distribution that only leads to the first term in the expansion given by Eq. ሺܣ21ሻ and (A22)  
݇ሺ݇ െ 1ሻሺ݇ െ 2ሻ… ሺ݇ െ ݎሻധധധധധധധധധധധധധധധധധധധധധധധധധധധധധധധധധ ൌ ധ݇௥																		ሺܣ23ሻ 
Hence 
݇௥ധധധ ൌ ധ݇௥ ൅ ܽ଴ଵ ധ݇௥ିଵ ൅ ܽ଴ଶ ധ݇௥ିଶ ൅ ⋯൅ ܽ଴௥ ധ݇,																		ሺܣ24ሻ																 with no dependence on Δ and lineal energy in Eq. (A24). Thus 
ݖ௥തതത ൌ ݖ̅௥ ൅ ܾ଴ଵݖ̅௥ିଵ ൅ ܾ଴ଶݖ̅௥ିଶ ൅ ⋯൅ ܾ଴௥ݖ̅.																		ሺܣ25ሻ Substituting these results into Eqs. (A12a-c), it is now straightforward to show that the Poisson 
distribution leads to no dependence of ߙ and ߚ on lineal energy and LET consistent with the 
results presented by Sachs et al. [46]. In contrast the Neyman’s distribution leads to a power 
law dependence of ߙ and ߚ on lineal energy and LET as discussed in the main text. The use of 
Neyman’s distribution in RMF-MCDS model reported by Carlson et al. in Ref. [33] where ݖி and LET are resulted linearly in ߙ where ߚ shows no dependence. One difference between 
derivation presented in our current study and the one presented in Ref. [33] is the incorporation 
of fluctuations that supersede ݖ஽, instead of ݖி in ߙ and ߚ such that the formulation of our linear model shows consistency with Hawkins’ MK linear models [28,29,49]. 
 
 
 
